Evidence map›Paper›PMID 26992948›Full record

Trial reportHaematologica2016

Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.

Silvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, Manuela Tosi, Barbara Peruta, Pamela Zanghi, Elena Oldani, Cristina Boschini, Alexander Kohlmann, Silvia Bungaro and 8 more

Open access · goldAbstract readClinical TrialLetter
In one paragraph

Trial report in Haematologica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. HemaSphere · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Expression of P53, MDM2, c-myc, and P14Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Silvia SalmoiraghiHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Marie Lorena Guinea MontalvoHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Greta UbialiHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Manuela TosiHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Barbara PerutaHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Pamela ZanghiHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Elena OldaniHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Cristina BoschiniHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Alexander KohlmannPersonalized Healthcare and Biomarkers, Innovative Medicines and Early Development, AstraZeneca, Cambridge, UK.
Silvia BungaroCentro Ricerche Tettamanti, Clinica Pediatrica Università Milano-Bicocca, Ospedale San Gerardo, Monza, Italy.
Tamara IntermesoliHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Elisabetta TerruzziDivisione di Ematologia e Trapianto di Midollo Osseo, Ospedale San Gerardo, Monza, Italy.
Emanuele AngelucciEmatologia e Centro Trapianti, Ospedale Oncologico di Riferimento Regionale "Armando Businco", Azienda Ospedaliera "Brotzu", Cagliari, Italy.
Irene CavattoniEmatologia e Centro Trapianti di Midollo Osseo, Ospedale Centrale, Bolzano, Italy.
Fabio CiceriHematology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Renato BassanHematology, Ospedale dell'Angelo, Mestre-Venezia, Italy.
Alessandro RambaldiDipartimento Scienze Cliniche e di Comunità, University of Milan, Italy Hematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy arambaldi@asst-pg23.it.
Orietta SpinelliHematology and Bone Marrow Transplant Unit of Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Ospedale Papa Giovanni XXIII · ITAstraZeneca (United Kingdom) · GBAzienda Ospedaliera G. Brotzu · ITAzienda Ospedaliera San Gerardo · ITOspedale dell' Angelo · ITUniversity of Milan · ITUniversity of Milano-Bicocca · ITVita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MutationPrecursor Cell Lymphoblastic Leukemia-LymphomaAdultDisease-Free SurvivalFemaleHumansMaleMiddle AgedSurvival RateTumor Suppressor Protein p53TP53 protein, humanTumor Suppressor Protein p53acute lymphoblastic leukemiaearly relapsesurvivalTP53 mutations

Identifiers

PMID26992948
PMCPMC5013945
OpenAlexW2298882365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.